Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ELUT
ELUT logo

ELUT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Elutia Inc (ELUT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.120
1 Day change
-2.61%
52 Week Range
2.750
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Elutia Inc (ELUT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance, and no strong trading signals suggest holding off on investment until clearer opportunities arise.

Technical Analysis

The MACD is positive and expanding, indicating a potential upward momentum. RSI is neutral at 65.84, and moving averages are converging, showing no clear trend. Key resistance levels are at 1.182 and 1.21, with support at 1.09 and 1.062. Overall, the technicals suggest a neutral to slightly bullish outlook.

Positive Catalysts

  • Insider buying has increased significantly by 1818.31% over the last month, which could indicate confidence from within the company.

Neutral/Negative Catalysts

  • No recent news or significant trading trends. Financial performance shows a massive YoY decline in net income (-881.27%) and EPS (-615.38%), which raises concerns about the company's profitability.

Financial Performance

In Q4 2025, revenue increased by 16.16% YoY, and gross margin improved by 24.62% to 58.51%. However, net income dropped significantly by -881.27%, and EPS fell by -615.38%, indicating poor profitability despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes available for this stock.

Wall Street analysts forecast ELUT stock price to rise
2 Analyst Rating
Wall Street analysts forecast ELUT stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.150
sliders
Low
2
Averages
3.5
High
5
Current: 1.150
sliders
Low
2
Averages
3.5
High
5
Cantor Fitzgerald
Overweight -> Overweight
downgrade
$7 -> $5
AI Analysis
2025-08-18
Reason
Cantor Fitzgerald
Price Target
$7 -> $5
AI Analysis
2025-08-18
downgrade
Overweight -> Overweight
Reason
Cantor Fitzgerald lowered the firm's price target on Elutia to $5 from $7 and keeps an Overweight rating on the shares.
Lake Street
Buy
downgrade
$10 -> $8
2025-05-09
Reason
Lake Street
Price Target
$10 -> $8
2025-05-09
downgrade
Buy
Reason
Lake Street lowered the firm's price target on Elutia to $8 from $10 and keeps a Buy rating on the shares. The firm thinks EluPro is "off to a remarkable start" and continues to believe a strategic exit materially above the company's current value is "the most likely outcome," though it reduced its price target on less value ascribed to SimpliDerm.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ELUT
Unlock Now

People Also Watch